Stock listing

NASDAQ:ELEV Elevation Oncology Inc Stock

Follow Elevation Oncology Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ELEV

$0.365 USD

Close on Jul 22, 2025 · No longer trades

Jun 25, 2021 to last close -96.8% · weekly closes, Jun 25, 2021 – Jul 22, 2025
Lowest – highest close
$0.233 – $16.110 USDSince Jun 25, 2021 · lowest Apr 8, 2025 · highest Jul 12, 2021

Delisted NASDAQ:ELEV no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ELEV
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Elevation Oncology Inc on 6ix

Calls
1 call with a replay · 1 with a transcript · latest Aug 6, 2024
Decks
3 decks · latest Apr 17, 2023

Events

CallWhenStatus
Elevation Oncology (ELEV) Q2 2024 Earnings CallTue, Aug 06, 2024 · 8:30 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Technical Presentation (April 2023)Technical20 slidesApr 17, 2023
Corporate Update (July 2022)Corporate update16 slidesJul 28, 2022
Corporate Update (May 2022)Corporate update21 slidesMay 27, 2022

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alan Sandler
Other companies: Revolution Medicines, Inc. (Chief Development Officer · Since at least Nov 5, 2025); ALX Oncology Holdings Inc. (Director · Since at least Aug 5, 2024); Zai Lab Ltd. (Head of Global Dev., Oncology · Jan 1, 2021 – Jun 25, 2022 · Past)
Director · Since at least Feb 29, 2024
David Dornan
Other companies: Whitehawk Therapeutics, Inc. (Chief Scientific Officer · Since at least Feb 18, 2025); Bolt Biotherapeutics, Inc. (Chief Scientific Officer · Feb 4, 2021 – Feb 18, 2022 · Past)
CHIEF SCIENTIFIC OFFICER · Mar 14, 2022 – Feb 15, 2025 · Past
Colin Walsh
Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026)
Director · Jun 24, 2021 – Jun 16, 2023 · Past
Julie M Cherrington
Other companies: Vaxart, Inc. (Director · Aug 20, 2021 – Aug 4, 2022 · Past)
Director · Since at least Feb 29, 2024
Valerie Jansen
Other companies: OnKure Therapeutics, Inc. (Director · Since at least Oct 4, 2024)
CHIEF MEDICAL OFFICER · Jan 6, 2023 – Feb 15, 2025 · Past
Darcy MootzDirector · Since at least Jan 18, 2024
Shawn LelandPresident, CEO, Director · Jun 24, 2021 – Feb 14, 2022 · Past
Tammy FurlongCHIEF FINANCIAL OFFICER · Since at least Jul 12, 2023

Open People

Log in to ask 6ix AI your own questions about Elevation Oncology Inc.